The Vaccine Debate 2
April 25, 2015
Posted by on
On September 23, 2014, a court in Milan, Italy, award compensation to a boy for vaccine-induced autism. The Labour Court of Milan ruled a childhood vaccine against six childhood diseases caused the boy’s permanent autism and brain damage.
The infant received three doses of GlaxoSmithKline’s Infanrix Hexa, a hexavalent vaccine administered in the first year of life. The vaccine is to protect children from polio, diphtheria, tetanus, hepatitis B, pertussis and Haemophilus influenza type B. In addition to these antigens, the vaccine then contained thimerosal, the mercury-containing preservative, and aluminum as an adjuvant.
The Court noted that Infanrix Hexa contained thimerosal, now banned in Italy because of its neurotoxicity, “in concentrations greatly exceeding the maximum recommended levels for infants weighing only a few kilograms.”
Presiding Judge Nicola Di Leo considered another piece of crucial evidence: a 1271-page confidential GlaxoSmithKline report (now available on the web). This industry document provided evidence of adverse events from the vaccine, including five known cases of autism resulting from the vaccine’s administration during its clinical trials.
The Italian Ministry of Health will have to pay a check every two months for life to the child. It will appeal the Court’s decision.